Literature DB >> 15726693

Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients.

Alba Muzzi1, Gioacchino Leandro, Laura Rubbia-Brandt, Richard James, Olivia Keiser, Raffaele Malinverni, Jean-François Dufour, Beat Helbling, Antoine Hadengue, Jean-Jacques Gonvers, Beat Müllhaupt, Andreas Cerny, Mario U Mondelli, Farncesco Negro.   

Abstract

BACKGROUND/AIMS: Liver steatosis is a frequent finding in chronic hepatitis C. An association has been suggested between steatosis and fibrosis progression rate, but the pathogenetic mechanisms linking fatty infiltration and collagen deposition are unknown.
METHODS: We measured the levels of insulin resistance (as HOMA score) and leptin in 221 non-diabetic chronic hepatitis C patients, to assess their impact on liver steatosis and fibrosis, relative to other factors, using a multivariable logistic regression.
RESULTS: When all 221 patients were considered, steatosis was associated with excessive alcohol intake, genotype 3, and serum HCV RNA level, whereas fibrosis was associated with HOMA score and age. In 152 patients infected with genotype non-3, steatosis was associated with alcohol abuse and HCV RNA level, and fibrosis with HOMA score and age. In the 69 patients with genotype 3, steatosis and fibrosis were associated with each other. The association between fibrosis and HOMA score held also when 22 obese patients were excluded from the analysis. Levels of insulin resistance were not correlated with the presence of steatosis.
CONCLUSIONS: Thus, insulin resistance (but not leptin) may play a role in fibrogenesis in chronic hepatitis C patients infected with genotype non-3.

Entities:  

Mesh:

Year:  2005        PMID: 15726693     DOI: 10.1016/j.jhep.2004.09.022

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  33 in total

Review 1.  Interaction between hepatitis C virus and metabolic factors.

Authors:  Yasunori Kawaguchi; Toshihiko Mizuta
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 2.  Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.

Authors:  Abdel-Rahman El-Zayadi; Mahmoud Anis
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

3.  Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients.

Authors:  Mohammed J Saeed; Margaret A Olsen; William G Powderly; Rachel M Presti
Journal:  J Clin Gastroenterol       Date:  2017-01       Impact factor: 3.062

Review 4.  Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review.

Authors:  Harleen K Dyal; Maria Aguilar; Taft Bhuket; Benny Liu; Edward W Holt; Sharon Torres; Ramsey Cheung; Robert J Wong
Journal:  Dig Dis Sci       Date:  2015-07-03       Impact factor: 3.199

5.  Insulin resistance, adipokine profile and hepatic expression of SOCS-3 gene in chronic hepatitis C.

Authors:  Kamila Wójcik; Elżbieta Jabłonowska; Aleksandra Omulecka; Anna Piekarska
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

6.  Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.

Authors:  Anna S Lok; James E Everhart; Raymond T Chung; Hae-Young Kim; Gregory T Everson; John C Hoefs; Joel K Greenson; Richard K Sterling; Karen L Lindsay; William M Lee; Adrian M Di Bisceglie; Herbert L Bonkovsky; Marc G Ghany; Chihiro Morishima
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

7.  Nutritional status in relation to lifestyle in patients with compensated viral cirrhosis.

Authors:  Fumikazu Hayashi; Chika Momoki; Miho Yuikawa; Yuko Simotani; Etsushi Kawamura; Atsushi Hagihara; Hideki Fujii; Sawako Kobayashi; Shuji Iwai; Hiroyasu Morikawa; Masaru Enomoto; Akihiro Tamori; Norifumi Kawada; Satoko Ohfuji; Wakaba Fukusima; Daiki Habu
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

Review 8.  A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.

Authors:  P Riley; J O'Donohue; M Crook
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

9.  Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.

Authors:  G Svegliati-Baroni; E Bugianesi; T Bouserhal; F Marini; F Ridolfi; F Tarsetti; F Ancarani; E Petrelli; E Peruzzi; M Lo Cascio; M Rizzetto; G Marchesini; A Benedetti
Journal:  Gut       Date:  2007-03-28       Impact factor: 23.059

Review 10.  Hepatitis C virus and type 2 diabetes.

Authors:  Francesco Negro; Mahnaz Alaei
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.